Schedule 13G ownership disclosure
APTEVO THERAPEUTICS INC
Security class unavailable · CUSIP: 03835L207
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 68,686
- Percent of class
- 1.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-22-000012
- Form type
- SC 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Feb 10, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership